NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) earnings
Quarterly results of NEUROONE MEDICAL TECHNOLOGIES Corp as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
NEUROONE MEDICAL TECHNOLOGIES Corp is expected to report around December 16, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended June 30, 2026) NEUROONE MEDICAL TECHNOLOGIES Corp reported revenue of $2M (+16.3% on the same quarter a year earlier) and a net loss of $2M.
Diluted earnings per share were -$0.28.
The latest results release
NeuroOne reported preliminary fourth quarter product revenue of approximately $3.8 million and secured a record $4.5 million purchase order.
Fourth quarter fiscal 2026 product revenue reached approximately $3.8 million, representing year-over-year growth of 38.4% compared to approximately $2.7 million in the fourth quarter of fiscal 2025.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $2M | +16.3% | -$2M | -$0.28 |
| Q2 FY2026 | $1.9M | +34.3% | -$2.4M | -$0.28 |
| Q1 FY2026 | $2.9M | -11.7% | -$1.4M | -$0.03 |
| Q4 FY2025 | $2.7M | +906.6% | -$1.6M | - |
| Q3 FY2025 | $1.7M | - | -$1.5M | -$0.19 |
| Q2 FY2025 | $1.4M | - | -$2.3M | -$0.44 |
| Q1 FY2025 | $3.3M | - | $1.8M | $0.06 |
| Q4 FY2024 | $272.3K | - | -$3.4M | - |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report (amended) 10-Q/A
- Quarterly report 10-Q
- Quarterly results 8-K
When is NEUROONE MEDICAL TECHNOLOGIES Corp's next earnings date?
NEUROONE MEDICAL TECHNOLOGIES Corp is expected to report around December 16, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were NEUROONE MEDICAL TECHNOLOGIES Corp's latest quarterly results?
For Q3 FY2026, which ended June 30, 2026, NEUROONE MEDICAL TECHNOLOGIES Corp reported revenue of $2M and a net loss of $2M. The figures come from its filing with the SEC.
Is NEUROONE MEDICAL TECHNOLOGIES Corp's revenue growing?
Revenue in Q3 FY2026 was $2M, up 16.3% from $1.7M in the same quarter a year earlier.
Get an email when NMTC reports
Follow NMTC and we email you its next results the day they are filed, with the numbers explained.